Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business Associate Provision Should Be Dropped From Privacy Rule - BCBSA

This article was originally published in The Gray Sheet

Executive Summary

Provisions requiring covered entities to establish contracts with business associates that receive identifiable information should be eliminated from HHS' medical privacy regulations, the Blue Cross/Blue Shield Association is recommending.

You may also be interested in...



Added Consent Demands Will Discourage Device Improvements - AdvaMed

Patient authorization requirements included in the final medical privacy rule will render informed consent superfluous and create obstacles to incremental medical device improvements, according to AdvaMed.

Added Consent Demands Will Discourage Device Improvements - AdvaMed

Patient authorization requirements included in the final medical privacy rule will render informed consent superfluous and create obstacles to incremental medical device improvements, according to AdvaMed.

Privacy Regs Allow Companies Patient Records For AE Reporting, Recalls

HHS' final privacy regulations specify that manufacturers can receive disclosures of protected health information from providers without patient consent only when the disclosure is made to an authorized employee for reporting adverse events or product defects, tracking products, enabling product recalls, or conducting postmarketing surveillance, under specific FDA direction or requirement.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel